Interestingly, we observed a tumor-independent enhancement of CD45+ cells in the CCl4 and DEN/CCl4-treated Cxcl10−/− mice compared to the WT counterparts (Figure 4A). The gene discussed is CXCL10; the disease is neoplasm.